Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

VIVO

Meridian Bioscience (VIVO)

Meridian Bioscience Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VIVO
FechaHoraFuenteTítuloSímboloCompañía
13/02/202315:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VIVOMeridian Bioscience Inc
09/02/202310:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VIVOMeridian Bioscience Inc
09/02/202307:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VIVOMeridian Bioscience Inc
06/02/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202313:34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202313:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202313:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202312:56PR Newswire (US)SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceNASDAQ:VIVOMeridian Bioscience Inc
31/01/202308:41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:VIVOMeridian Bioscience Inc
25/01/202316:58PR Newswire (US)DoubleVerify Holdings to Join S&P SmallCap 600NASDAQ:VIVOMeridian Bioscience Inc
10/01/202316:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VIVOMeridian Bioscience Inc
12/12/202207:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VIVOMeridian Bioscience Inc
12/12/202207:00PR Newswire (US)Meridian Bioscience Announces Anticipated Closing Date of the Pending MergerNASDAQ:VIVOMeridian Bioscience Inc
22/11/202207:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VIVOMeridian Bioscience Inc
22/11/202207:00PR Newswire (US)MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTSNASDAQ:VIVOMeridian Bioscience Inc
30/09/202216:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VIVOMeridian Bioscience Inc
19/09/202211:24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:VIVOMeridian Bioscience Inc
25/08/202215:52Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:VIVOMeridian Bioscience Inc
08/08/202205:30TipRanksAnalysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Meridian Bioscience (VIVO) and Neurocrine (NBIX)NASDAQ:VIVOMeridian Bioscience Inc
05/08/202207:00PR Newswire (US)MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTSNASDAQ:VIVOMeridian Bioscience Inc
29/07/202208:23PR Newswire (US)Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular AssayNASDAQ:VIVOMeridian Bioscience Inc
07/07/202206:17PR Newswire (US)Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash TransactionNASDAQ:VIVOMeridian Bioscience Inc
07/07/202206:12PR Newswire (US)Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third QuarterNASDAQ:VIVOMeridian Bioscience Inc
20/06/202207:38PR Newswire (US)Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular AssaysNASDAQ:VIVOMeridian Bioscience Inc
27/05/202207:15Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:VIVOMeridian Bioscience Inc
26/05/202212:31PR Newswire (US)Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular TestsNASDAQ:VIVOMeridian Bioscience Inc
23/05/202212:13PR Newswire (US)Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment ConferenceNASDAQ:VIVOMeridian Bioscience Inc
17/05/202214:33PR Newswire (US)Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic AssaysNASDAQ:VIVOMeridian Bioscience Inc
09/05/202205:15TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VIVOMeridian Bioscience Inc
06/05/202207:00PR Newswire (US)MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTSNASDAQ:VIVOMeridian Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:VIVO

Su Consulta Reciente

Delayed Upgrade Clock